Relapsed Marginal Zone Lymphoma

DBCOND0092875Hematologic Neoplasms

Relapsed Marginal Zone Lymphoma is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Classified under
Indicated drugs

What you can answer from here — as of November 01, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Relapsed Marginal Zone Lymphoma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In